Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beigene | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥173.85B | -0.3x | -1.77 | CN¥190.69 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.3% Upside | Upgrade to Pro+ | |
WuXi AppTec | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥158.33B | 18.5x | -1.3 | CN¥55.36 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21% Upside | Upgrade to Pro+ | |
Pharmaron Beijing | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥40.55B | 23.5x | 1.01 | CN¥24.85 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.7% Upside | Upgrade to Pro+ | |
Hangzhou Tigermed Consulting | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥39.21B | 44.2x | -0.71 | CN¥49 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.1% Upside | Upgrade to Pro+ | |
Shanghai Allist Pharmaceuticals Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥30.75B | 19.8x | 0.14 | CN¥68.33 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.8% Upside | Upgrade to Pro+ | |
Dizal Jiangsu Pharmaceutical | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥17.37B | -20.2x | -0.97 | CN¥41.59 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.6% Upside | Upgrade to Pro+ | |
Sinocelltech Group | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥15.96B | -662.8x | -6.64 | CN¥35.84 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BGI Genomics | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥14.83B | -156x | 0.8 | CN¥38.89 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RemeGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥12.14B | -5.5x | 0.46 | CN¥27.86 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.3% Upside | Upgrade to Pro+ | |
InnoCare Pharma | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥10.93B | -28.9x | -1.91 | CN¥12.15 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Joinn Laboratories China | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥10.92B | -16,150x | CN¥16.08 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.4% Downside | Upgrade to Pro+ | ||
Bio-Thera Solutions | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥7.71B | -20.6x | -0.54 | CN¥18.63 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
InventisBio | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥7.57B | -21.2x | 16.89 | CN¥13.13 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.5% Upside | Upgrade to Pro+ | |
Sino Biological | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥7.24B | 54.5x | -1.42 | CN¥59.50 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.6% Upside | Upgrade to Pro+ | |
Mabwell Shanghai Bioscience | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥6.24B | -6.4x | 0.44 | CN¥15.61 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GemPharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.33B | 38.4x | -3.59 | CN¥13.06 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.2% Upside | Upgrade to Pro+ | |
HitGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.89B | 90.9x | 1.41 | CN¥12.23 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27% Upside | Upgrade to Pro+ | |
R G PharmaStudies | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥4.55B | 31.4x | -9.1 | CN¥47.13 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.2% Upside | Upgrade to Pro+ | |
Bide Pharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.28B | 54.2x | -0.91 | CN¥48.48 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.1% Upside | Upgrade to Pro+ | |
Shanghai Aladdin Biochemical Technology Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.19B | 34x | 0.97 | CN¥15.12 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.4% Downside | Upgrade to Pro+ | |
Beijing Sun Novo Pharmaceutical Research | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.91B | 21.7x | 1.65 | CN¥34.87 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beijing Kawin Technology Shareholding Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.79B | 26.6x | 0.69 | CN¥22.65 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jiangsu Asieris Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.77B | -9x | 0.55 | CN¥6.72 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31% Upside | Upgrade to Pro+ | |
Hangzhou BioSincerity PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.69B | 21x | -1.15 | CN¥34.06 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shanghai Medicilon | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.67B | -17.6x | 0.05 | CN¥27.49 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaResources Shanghai | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.55B | 478.1x | -5.63 | CN¥25.78 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guangzhou Boji Medical & Biotech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.17B | 71.4x | 1.49 | CN¥8.34 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.8% Upside | Upgrade to Pro+ | |
Qingdao Vland Biotech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥2.99B | 45.5x | -11.41 | CN¥11.81 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ChemPartner PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥2.97B | -3.2x | 0.07 | CN¥5.98 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hinova Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥2.83B | -13.6x | -0.39 | CN¥28.58 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anhui Wanbang Pharmaceutical | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥2.55B | 23.4x | -0.99 | CN¥38.20 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Xinjiang Baihuacun | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥2.51B | 130.4x | 0.78 | CN¥6.56 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |